A complete patient and caregiver guide to how Medicare Part B covers mobile wound care visits, debridement, skin substitutes, and what you actually pay out of pocket in 2025.
Healix360 supports access to advanced mobile wound care services. Care is coordinated and provided directly by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds. For patients enrolled in Original Medicare, that home-based care is delivered, billed, and documented under the same Medicare Part B framework that governs office-based wound care—so the protections, coverage rules, and patient cost-shares you already know still apply, just inside your living room instead of a clinic exam room.
Medicare Part B covers medically necessary mobile wound care delivered in the patient's home, an assisted living community, a custodial care facility, or a skilled nursing facility (under Part B for the professional component). After the annual Part B deductible (approximately $240 in 2025), Medicare pays 80% of the Medicare-allowed amount for evaluation and management visits, surgical debridement (CPT 11042–11047), application of cellular and tissue-based skin substitutes (Q4100-series Q-codes), and most supplies billed incident-to. The remaining 20% is the patient's coinsurance, which is typically picked up by a Medigap plan, Medicaid (for dual-eligible beneficiaries), or paid out of pocket. There is no separate facility fee for a home visit because the place of service is POS 12 (Home), not a hospital outpatient department.
Original Medicare has two main parts that matter for wound care. Part A covers inpatient hospital stays and short-term skilled nursing facility (SNF) stays after a qualifying hospitalization. Part B covers outpatient and professional services—including physician visits, nurse practitioner visits, surgical procedures performed outside the hospital, durable medical equipment, and most diagnostic testing. Mobile wound care, even when delivered in the home, is a Part B benefit because the clinician is providing professional services rather than admitting the patient to a facility.
Medicare Part B is administered through Medicare Administrative Contractors (MACs) that publish Local Coverage Determinations (LCDs) describing exactly which services are covered, for which diagnoses, and how often. The most relevant national framework for chronic wound care is LCD L35041 (Wound Care), which covers debridement, dressings, and the documentation requirements for advanced therapies. Healix360–coordinated clinicians document every visit to those LCD standards so claims are paid the first time and patients aren't left with surprise denials.
Coverage is built around medical necessity. Medicare pays for services that a reasonable clinician would order to evaluate, diagnose, and treat a chronic or complex wound. In practical terms, a Healix360–coordinated visit usually includes a focused history, a comprehensive wound assessment, photo documentation, debridement when devitalized tissue is present, dressing selection or change, and patient/caregiver education. Each component has a specific Current Procedural Terminology (CPT) or Healthcare Common Procedure Coding System (HCPCS) code that drives reimbursement.
The first visit is typically billed as a new patient home or domiciliary E/M (CPT 99341–99345), and follow-up visits are billed as established patient codes (CPT 99347–99350). Code selection is based on either total time spent on the date of the encounter or medical decision-making complexity. Chronic non-healing wounds with comorbid diabetes, peripheral arterial disease, or infection routinely meet moderate or high complexity criteria, supporting appropriate code level selection.
Advanced biologics—such as EpiFix and AmnioBand (placental allografts), Apligraf and Dermagraft (bioengineered living constructs), Integra (collagen-glycosaminoglycan matrix), and PROMOGRAN (collagen/ORC matrix)—are billed using Q4100-series Q-codes for the product itself and CPT 15271–15278 for application. Coverage is governed by the MAC's local skin substitute policy, which generally requires four weeks of documented standard care without ≥50% area reduction before initiating advanced therapy on a diabetic foot ulcer or venous leg ulcer. Healix360–coordinated clinicians complete that documentation prospectively so therapy is not delayed.
Out-of-pocket cost under Original Medicare follows a predictable formula. The 2025 Part B annual deductible is approximately $240 (CMS finalizes this figure each fall). Once the deductible is met, Medicare pays 80% of the Medicare-allowed amount and the patient is responsible for the remaining 20% coinsurance. There is no Part B annual out-of-pocket maximum under Original Medicare—which is the single biggest reason most beneficiaries carry a Medigap (Medicare Supplement) plan.
If your weekly wound care visit has a Medicare-allowed amount of $150 and you have already met the deductible, Medicare pays $120 and you owe $30. With a Medigap Plan G, your $30 coinsurance is paid by the supplement and your out-of-pocket cost for the visit is $0.
Patients who are dual-eligible for Medicare and Medicaid—often called Medi-Medi in California—generally pay nothing out of pocket for covered wound care services. Medicaid acts as the secondary payer and covers the Medicare deductible and coinsurance, subject to state-specific cost-sharing rules. Healix360 intake teams verify both Medicare and Medicaid coverage during the referral process so dual-eligible patients can begin care without financial uncertainty.
Medicare Advantage plans (Part C) are private insurance plans that contract with CMS to deliver Part A and Part B benefits. By federal law, MA plans must cover everything Original Medicare covers, but they are allowed to apply prior authorization, network restrictions, and plan-specific cost-sharing. As of 2025, more than half of all Medicare beneficiaries are enrolled in MA plans, so understanding the differences is essential for patients considering mobile wound care.
Healix360 verifies Medicare Advantage benefits, network status, prior-authorization requirements, and plan-specific cost-shares before scheduling the first appointment so patients know exactly what to expect financially. Call 877-545-1300 with your member ID handy.
The CMS Acute Hospital Care at Home (AHCAH) waiver program, originally launched during the COVID-19 public health emergency and extended by Congress through legislation in 2024, allows qualifying hospitals to deliver hospital-level care in the patient's home. AHCAH patients commonly have complex wounds—post-surgical dehiscence, infected diabetic ulcers, or stage 4 pressure injuries—that require coordinated specialist input. Healix360 supports AHCAH-enrolled patients with the same Part B–billable wound care visits used in traditional home settings, allowing the discharging hospital's transition team to offload long-term wound management while the patient remains under hospital-at-home oversight.
From a patient's perspective, documentation might seem like back-office paperwork. In Medicare wound care, however, documentation is what determines whether your claim is paid. Healix360–coordinated clinicians document each visit to the requirements of LCD L35041 and the relevant skin substitute LCDs, including wound measurements (length × width × depth), tissue type percentages (granulation, slough, eschar, epithelial), exudate volume and character, periwound condition, pain score, and a clear medical-necessity statement explaining why the chosen procedure was performed.
Patients and families frequently encounter myths about Medicare and home-based care. Two of the most damaging are the belief that you must be 'homebound' to receive in-home physician services, and the belief that home visits are not 'real' Medicare-covered care. Both are wrong. Homebound status is a requirement for Medicare Part A home health agency benefits—not for Part B physician or nurse practitioner house calls. A patient does not need to be homebound to receive Healix360–coordinated wound care at home; they simply need a medically necessary wound that benefits from in-home evaluation and treatment.
If a patient is in a Part A–covered SNF stay following a qualifying hospitalization, the SNF receives a bundled per-diem payment that covers room, board, nursing care, and most ancillary services. Professional fees for physician and nurse practitioner visits, however, remain billable under Part B and are not bundled. That means a Healix360–coordinated wound care specialist can see the patient at the SNF during the Part A stay and bill the visit and any debridement procedures to Part B without affecting the SNF's bundled payment.
Hospice is different. When a patient elects the Medicare Hospice Benefit, all care related to the terminal diagnosis is covered by the hospice agency under a per-diem capitated payment. Wound care that is unrelated to the hospice diagnosis can still be billed to Part B by an outside provider, but care related to the terminal diagnosis must be coordinated through the hospice. Healix360 works closely with hospice teams to ensure appropriate billing pathways and seamless symptom-focused wound management.
"Patients are often shocked to learn that the same wound care they would receive in a hospital outpatient department—performed by the same caliber of clinician, using the same biologics—can be delivered at the kitchen table for a lower out-of-pocket cost because there is no facility fee." — Healix360 Clinical Team
Healix360 supports Medicare Part B mobile wound care across nine Southern California counties—Los Angeles, Orange, Riverside, San Bernardino, Ventura, Santa Barbara, Kern, San Luis Obispo, and San Diego—plus the Las Vegas metropolitan area covering Clark and Nye counties in Nevada. Headquarters: Glendale, California.
The annual Medicare Part B deductible for 2025 is approximately $240, finalized by CMS each fall. The deductible applies to the first Part B services of the calendar year, including mobile wound care visits, and resets every January 1. Once met, Medicare pays 80% of the allowed amount and you (or your secondary insurance) pay the remaining 20%.
Yes. Medicare Part B covers medically necessary professional wound care services delivered in the patient's home (place of service code 12), assisted living facility (POS 13), nursing facility (POS 32), or SNF (POS 31). You do not need to be classified as homebound to receive these Part B house-call services—homebound status is a separate requirement that applies only to Medicare Part A home health agency benefits.
After meeting the annual Part B deductible, you owe 20% coinsurance of the Medicare-allowed amount for each visit and procedure. For a typical home E/M visit with debridement, that is often $25–$60. If you have Medigap Plan G or Plan N, the supplement pays the coinsurance and your out-of-pocket cost is usually $0. Dual-eligible patients with Medicaid also typically pay nothing.
Yes, when medical necessity is documented per the relevant Local Coverage Determination. Most MACs require four weeks of conservative care without at least 50% wound area reduction before initiating Q4100-series cellular therapies on diabetic foot ulcers and venous leg ulcers. Healix360–coordinated clinicians prospectively document those criteria so therapy can begin on schedule, and the product itself plus the application CPT (15271–15278) are both billed to Part B.
Medicare Advantage (Part C) plans must cover the same services as Original Medicare, but they may apply prior authorization, network restrictions, and plan-specific copays instead of the standard 20% coinsurance. Some plans require step therapy through lower-cost dressings before approving advanced biologics. Healix360 verifies MA benefits, secures prior authorizations, and confirms in-network status before the first scheduled visit so there are no billing surprises.
LCD L35041 is the Local Coverage Determination that defines what wound care services Medicare covers, including documentation standards for debridement frequency, dressing selection, and progress monitoring. As a patient, you don't have to read it—but the clinicians coordinated by Healix360 document each visit specifically to its requirements, which is why our claims are paid at high first-pass rates and patients rarely receive surprise denials or appeals.
No. A facility fee is a charge that hospital outpatient departments (HOPDs) bill on top of the physician's professional fee. Because mobile wound care is delivered in the home (POS 12) and not in a hospital, there is no facility fee. You will see only one professional fee billed to Medicare for each visit—generally far less than the combined professional plus facility fee for the same service performed at a hospital wound center.
Yes. The SNF receives a bundled per-diem payment under Part A that covers room, board, and routine nursing services, but professional fees for physician or nurse practitioner specialist visits remain billable to Part B and are not bundled. Healix360–coordinated wound specialists routinely visit patients during Part A SNF stays and bill the professional services to Part B without any cost impact to the SNF.
Patients dual-eligible for Medicare and California Medi-Cal (or Medicaid in other states) generally pay nothing out of pocket. Medicare pays 80% as the primary payer, and Medi-Cal acts as the secondary payer for the deductible and 20% coinsurance, subject to state-specific cost-sharing rules. Healix360 intake confirms both coverages before the first visit and handles dual-claim submission.
A formal referral is not required to initiate care—patients, family members, hospital discharge planners, SNF directors of nursing, and home health agencies can all request Healix360 coordination directly by calling 877-545-1300. We will, however, coordinate with your primary care provider to keep them informed and ensure continuity of your overall care plan, including communication of wound assessments, debridement notes, and treatment decisions.
Most initial home evaluations are scheduled within 24 to 72 hours of the intake call, depending on geography, urgency, and benefit verification timing. Medicare Advantage prior authorizations may add a few days but Healix360 expedites these on a clinical-urgency basis. Same-day visits are sometimes possible for urgent post-discharge wounds when capacity allows in your service area.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.